Hymowitz N, Brezenoff H E, McGee J, Campbell K, Knight V
Psychopharmacology (Berl). 1985;86(4):404-8. doi: 10.1007/BF00427899.
Intraperitoneal (IP) administration of the acetylcholinesterase inhibitor, soman (10-40 micrograms/kg), suppressed in a dose-related manner response rates in rats maintained under a multiple fixed-interval 50-s fixed-ratio 25 schedule of food delivery. Chronic administration of soman at weekly intervals resulted in tolerance to the response. When soman administration was separated by 2-5 weeks in individual rats, the suppressive effects of the agent again became apparent. Analysis of acetylcholinesterase activity revealed that enzyme inhibition was limited to gastrointestinal areas near the site of injection. There was no significant effect on brain acetylcholinesterase even following IP injection of doses which completely suppressed responding. The IP route may be useful for studying tolerance and other chronic effects of soman without producing generalized toxicity.
腹腔内(IP)注射乙酰胆碱酯酶抑制剂梭曼(10 - 40微克/千克),以剂量相关的方式抑制了按多重固定间隔50秒固定比率25的食物递送时间表饲养的大鼠的反应率。每周间隔慢性注射梭曼导致对该反应产生耐受性。当在个体大鼠中梭曼注射间隔2 - 5周时,该药物的抑制作用再次变得明显。乙酰胆碱酯酶活性分析表明,酶抑制仅限于注射部位附近的胃肠道区域。即使腹腔内注射完全抑制反应的剂量,对脑乙酰胆碱酯酶也没有显著影响。腹腔内给药途径可能有助于研究梭曼的耐受性和其他慢性效应,而不会产生全身性毒性。